1/
Marofi, F., Vahedi, G., Biglari, A., Esmaeilzadeh, A., Athari, S.S.
Mesenchymal stromal/stem cells: A new era in the cell-based targeted gene therapy of cancer.
Frontiers in Immunology, Volume 8, Issue DEC, 18 December 2017, Article number 1770
2/
Arezumand, R., Alibakhshi, A., Ranjbari, J., Ramazani, A., Muyldermans, S.
Nanobodies as novel agents for targeting angiogenesis in solid cancers.
Frontiers in Immunology, Volume 8, Issue DEC, 8 December 2017, Article number 1746
3/
Nejati-Koshki, K., Pilehvar-Soltanahmadi, Y., Alizadeh, E., (...), Mortazavi, Y., Zarghami, N.
Development of Emu oil-loaded PCL/collagen bioactive nanofibers for proliferation and stemness preservation of human adipose-derived stem cells: possible application in regenerative medicine.
Drug Development and Industrial Pharmacy, Volume 43, Issue 12, 2 December 2017, Pages 1978-1988.
4/
Danafar, H., Sharaïfi, A., Askarlou, S., Manjili, H.K.
Preparation and Characterization of PEGylated Iron Oxide-Gold Nanoparticles for Delivery of Sulforaphane and Curcumin.
Drug Research, Volume 67, Issue 12, 1 December 2017, Pages 698-704
5/
Nasehi, F., Karshenas, M., Nadri, S., Barati, G., Salim, A.
Core-shell fibrous scaffold as a vehicle for sustained release of retinal pigmented epithelium-derived factor (PEDF) for photoreceptor differentiation of conjunctiva mesenchymal stem cells.
Journal of Biomedical Materials Research - Part A, Volume 105, Issue 12, December 2017, Pages 3514-3519
6/
Mardani, S., Maghsoodi, M., Ghanbarzadeh, S., (...), Yaqoubi, S., Hamishehkar, H.
Preparation and characterization of Celecoxib agglomerated nanocrystals and dry powder inhalation formulations to improve its aerosolization performance.
Pharmaceutical Sciences, Volume 24, Issue 4, 1 December 2017, Pages 278-284
7/
Nosrati, H., Salehiabar, M., Davaran, S., (...), Manjili, H.K., Danafar, H.
New advances strategies for surface functionalization of iron oxide magnetic nano particles (IONPs).
Research on Chemical Intermediates, Volume 43, Issue 12, 1 December 2017, Pages 7423-7442
8/
Kheiri Manjili, H., Sharafi, A., Attari, E., Danafar, H.
Pharmacokinetics and in vitro and in vivo delivery of sulforaphane by PCL–PEG–PCL copolymeric-based micelles Artificial Cells.
Nanomedicine and Biotechnology, Volume 45, Issue 8, 17 November 2017, Pages 1728-1739
9/
Danafar, H., Rostamizadeh, K., Davaran, S., Hamidi, M.
Co-delivery of hydrophilic and hydrophobic drugs by micelles: a new approach using drug conjugated PEG–PCLNanoparticles.
Drug Development and Industrial Pharmacy, Volume 43, Issue 11, 2 November 2017, Pages 1908-1918
10/
Saburi, E., Tavakol-Afshari, J., Biglari, S., Mortazavi, Y.
Is α-N-acetylgalactosaminidase the key to curing cancer? A mini-review and hypothesis.
Journal of B.U.ON. Volume 22, Issue 6, November-December 2017, Pages 1372-1377
11/
Moghadam, S., Erfanmanesh, M., Esmaeilzadeh, A.
Interleukin 35 and Hepatocyte Growth Factor; as a novel combined immune gene therapy for Multiple Sclerosis disease.
Medical Hypotheses, Volume 109, November 2017, Pages 102-105
12/
Jamali, S., Mostafavi, H., Barati, G., Eskandari, M., Nadri, S.
Differentiation of mesenchymal stem cells -derived trabecular meshwork into dopaminergic neuron-like cells on nanofibrous scaffolds.
Biologicals, Volume 50, November 2017, Pages 49-54
13/
Enderami, S.E., Mortazavi, Y., Soleimani, M., (...), Biglari, A., Mansour, R.N.
Generation of Insulin-Producing Cells From Human-Induced Pluripotent Stem Cells Using a Stepwise Differentiation Protocol Optimized With Platelet-Rich Plasma.
Journal of Cellular Physiology, Volume 232, Issue 10, October 2017, Pages 2878-2886
14/
Saburi, E., Tavakolafshari, J., Mortazavi, Y., (...), Mirzaei, S.A., Nadri, S.
shRNA-mediated downregulation of α-N-acetylgalactosaminidase inhibits migration and invasion of cancer cell lines.
Iranian Journal of Basic Medical Sciences, Volume 20, Issue 9, September 2017, Pages 1029-1036
15/
Azimi, F., Esmaeilzadeh, A., Ramazani, A.
Retraction notice to “Clinical significance of ITPA rs67002563 polymorphism in patients with acute lymphoblastic leukemia treated with 6-mercaptopurine” (Pharmacol. Res. (2015) 121 (61–62) (S1043661815002194) (10.1016/j.phrs.2015.09.015)).
Pharmacological Research, Volume 121, July 2017, Page 254
16/
Nejad, L.D., Biglari, A., Annese, T., Ribatti, D.
Recombinant fibromodulin and decorin effects on NF-κB and TGFβ1 in the 4T1 breast cancer cell line.
Oncology Letters, Volume 13, Issue 6, June 2017, Pages 4475-4480
17/
Nejati-Koshki, K., Mortazavi, Y., Pilehvar-Soltanahmadi, Y., Sheoran, S., Zarghami, N.
An update on application of nanotechnology and stem cells in spinal cord injury regeneration.
Biomedicine and Pharmacotherapy, Volume 90, 1 June 2017, Pages 85-92.
18/
Gharebaghi, F., Dalali, N., Ahmadi, E., Danafar, H.
Preparation of wormlike polymeric nanoparticles coated with silica for delivery of methotrexate and evaluation of anticancer activity against MCF7 cells.
Journal of Biomaterials Applications, Volume 31, Issue 9, 1 April 2017, Pages 1305-1316
19/
Nadri, S., Nasehi, F., Barati, G.
Effect of parameters on the quality of core-shell fibrous scaffold for retinal differentiation of conjunctiva mesenchymal stem cells.
Journal of Biomedical Materials Research - Part A, Volume 105, Issue 1, 1 January 2017, Pages 189-197
20/
Farshbaf, A., Biglari, A.R., Faghihzadeh, S., Esmaeilzadeh, A.R.
Frequency of CCR5Δ32 allelic mutation in healthy individuals in Zanjan Province.
Journal of Zanjan University of Medical Sciences and Health Services, Volume 25, Issue 108, 2017, Pages 129-136.
|
